*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C73 - Malignant neoplasm of thyroid gland - as a primary diagnosis code | C73 - Malignant neoplasm of thyroid gland - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.07 | |
| Readmission Rate (%) | 19.79 | |
| Unplanned Readmission Rate (%) | 7.47 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 626: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 627: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 625: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 645: ENDOCRINE DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 4,373 | ||||
| Total Hospitalizations with ICD C73 - Malignant neoplasm of thyroid gland | 2,005 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C73 - Malignant neoplasm of thyroid gland in DRG | 32.14 | ||||
| Avg LOS at DRG | 3.11 | ||||
| Avg LOS with ICD C73 - Malignant neoplasm of thyroid gland | 2.72 | ||||
| Readmission Rate at DRG | 10.79 | ||||
| Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 9.48 | ||||
| Unplanned Readmission Rate at DRG | 7.01 | ||||
| Unplanned Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 5.93 | ||||
| Total Medicare payments at DRG | $41,293,037 | ||||
| Total Medicare payments with ICD C73 - Malignant neoplasm of thyroid gland | $20,082,193 | ||||
| Total Medicare payment per Day at DRG | $3,036 | ||||
| Total Medicare payment per Day with ICD C73 - Malignant neoplasm of thyroid gland | $3,683 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,443 | ||||
| Total Medicare payment per Hospitalization with ICD C73 - Malignant neoplasm of thyroid gland | $10,016 | ||||
| Total Medicare Charges at DRG | $271,493,595 | ||||
| Total Medicare Charges with ICD C73 - Malignant neoplasm of thyroid gland | $134,070,192 | ||||
| Avg Charges at DRG | $62,084 | ||||
| Avg Charges with ICD C73 - Malignant neoplasm of thyroid gland | $66,868 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| SNF Discharge Rate at DRG | 4.64 | ||||
| SNF Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 2.14 | ||||
| Home Discharge Rate at DRG | 84.36 | ||||
| Home Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 88.03 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 643: ENDOCRINE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 629: OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 630: OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURSE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 30,462 | ||||
| Total Hospitalizations with ICD C73 - Malignant neoplasm of thyroid gland | 343 | ||||
| DRG Share of Total Hospitalizations | 0.09 | ||||
| % of Total ICD C73 - Malignant neoplasm of thyroid gland in DRG | 5.5 | ||||
| Avg LOS at DRG | 6.32 | ||||
| Avg LOS with ICD C73 - Malignant neoplasm of thyroid gland | 7.97 | ||||
| Readmission Rate at DRG | 26.57 | ||||
| Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 25.29 | ||||
| Unplanned Readmission Rate at DRG | 18.51 | ||||
| Unplanned Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 19.46 | ||||
| Total Medicare payments at DRG | $317,594,799 | ||||
| Total Medicare payments with ICD C73 - Malignant neoplasm of thyroid gland | $4,572,847 | ||||
| Total Medicare payment per Day at DRG | $1,651 | ||||
| Total Medicare payment per Day with ICD C73 - Malignant neoplasm of thyroid gland | $1,673 | ||||
| Total Medicare payment per Hospitalization at DRG | $10,426 | ||||
| Total Medicare payment per Hospitalization with ICD C73 - Malignant neoplasm of thyroid gland | $13,332 | ||||
| Total Medicare Charges at DRG | $1,554,071,419 | ||||
| Total Medicare Charges with ICD C73 - Malignant neoplasm of thyroid gland | $24,279,855 | ||||
| Avg Charges at DRG | $51,017 | ||||
| Avg Charges with ICD C73 - Malignant neoplasm of thyroid gland | $70,787 | ||||
| Mortality Rate at DRG | 2.85 | ||||
| Mortality Rate with ICD C73 - Malignant neoplasm of thyroid gland | 18.95 | ||||
| SNF Discharge Rate at DRG | 31.13 | ||||
| SNF Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 10.5 | ||||
| Home Discharge Rate at DRG | 31.18 | ||||
| Home Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 26.82 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | DRG 628: OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 623: SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 624: SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 013: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 48,449 | ||||
| Total Hospitalizations with ICD C73 - Malignant neoplasm of thyroid gland | 56 | ||||
| DRG Share of Total Hospitalizations | 0.15 | ||||
| % of Total ICD C73 - Malignant neoplasm of thyroid gland in DRG | 0.9 | ||||
| Avg LOS at DRG | 29.97 | ||||
| Avg LOS with ICD C73 - Malignant neoplasm of thyroid gland | 24.88 | ||||
| Readmission Rate at DRG | 76.3 | ||||
| Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 58.7 | ||||
| Unplanned Readmission Rate at DRG | 6.46 | ||||
| Unplanned Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| Total Medicare payments at DRG | $6,190,071,785 | ||||
| Total Medicare payments with ICD C73 - Malignant neoplasm of thyroid gland | $6,386,957 | ||||
| Total Medicare payment per Day at DRG | $4,263 | ||||
| Total Medicare payment per Day with ICD C73 - Malignant neoplasm of thyroid gland | $4,585 | ||||
| Total Medicare payment per Hospitalization at DRG | $127,765 | ||||
| Total Medicare payment per Hospitalization with ICD C73 - Malignant neoplasm of thyroid gland | $114,053 | ||||
| Total Medicare Charges at DRG | $28,754,600,069 | ||||
| Total Medicare Charges with ICD C73 - Malignant neoplasm of thyroid gland | $21,964,192 | ||||
| Avg Charges at DRG | $593,502 | ||||
| Avg Charges with ICD C73 - Malignant neoplasm of thyroid gland | $392,218 | ||||
| Mortality Rate at DRG | 20.61 | ||||
| Mortality Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| SNF Discharge Rate at DRG | 12.46 | ||||
| SNF Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| Home Discharge Rate at DRG | 2.36 | ||||
| Home Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 52,726 | |
| Total Hospitalizations with ICD C73 - Malignant neoplasm of thyroid gland | 21 | |
| DRG Share of Total Hospitalizations | 0.16 | |
| % of Total ICD C73 - Malignant neoplasm of thyroid gland in DRG | 0.34 | |
| Avg LOS at DRG | 6.68 | |
| Avg LOS with ICD C73 - Malignant neoplasm of thyroid gland | 6.24 | |
| Readmission Rate at DRG | 24.76 | |
| Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | |
| Unplanned Readmission Rate at DRG | 14.45 | |
| Unplanned Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | |
| Total Medicare payments at DRG | $902,862,104 | |
| Total Medicare payments with ICD C73 - Malignant neoplasm of thyroid gland | $281,053 | |
| Total Medicare payment per Day at DRG | $2,565 | |
| Total Medicare payment per Day with ICD C73 - Malignant neoplasm of thyroid gland | $2,145 | |
| Total Medicare payment per Hospitalization at DRG | $17,124 | |
| Total Medicare payment per Hospitalization with ICD C73 - Malignant neoplasm of thyroid gland | $13,383 | |
| Total Medicare Charges at DRG | $4,216,562,728 | |
| Total Medicare Charges with ICD C73 - Malignant neoplasm of thyroid gland | $1,663,825 | |
| Avg Charges at DRG | $79,971 | |
| Avg Charges with ICD C73 - Malignant neoplasm of thyroid gland | $79,230 | |
| Mortality Rate at DRG | 0.83 | |
| Mortality Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | |
| SNF Discharge Rate at DRG | 22.41 | |
| SNF Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | |
| Home Discharge Rate at DRG | 43.51 | |
| Home Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 57.14 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 101 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 61 |
| TAMPA GENERAL HOSPITAL | 1 TAMPA GENERAL CIRCLE | TAMPA | FL | 33606 | 60 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. GARY LEE CLAYMAN | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 48 |
| Dr. MARK EDWIN ZAFEREO | 1515 HOLCOMBE BLVD UNIT 1445 | HOUSTON | TX | 77030 | 39 |
| Dr. ASHOK R SHAHA | 1275 YORK AVE | NEW YORK | NY | 10021 | 27 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. GARY LEE CLAYMAN | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 51 |
| Dr. MARK EDWIN ZAFEREO | 1515 HOLCOMBE BLVD UNIT 1445 | HOUSTON | TX | 77030 | 40 |
| Dr. ASHOK R SHAHA | 1275 YORK AVE | NEW YORK | NY | 10021 | 26 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 626: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 627: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 625: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 4,373 | ||||
| Total Hospitalizations with ICD C73 - Malignant neoplasm of thyroid gland | 2,031 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C73 - Malignant neoplasm of thyroid gland in DRG | 11.93 | ||||
| Avg LOS at DRG | 3.11 | ||||
| Avg LOS with ICD C73 - Malignant neoplasm of thyroid gland | 2.72 | ||||
| Readmission Rate at DRG | 10.79 | ||||
| Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 9.56 | ||||
| Unplanned Readmission Rate at DRG | 7.01 | ||||
| Unplanned Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 6.0 | ||||
| Total Medicare payments at DRG | $41,293,037 | ||||
| Total Medicare payments with ICD C73 - Malignant neoplasm of thyroid gland | $20,266,176 | ||||
| Total Medicare payment per Day at DRG | $3,036 | ||||
| Total Medicare payment per Day with ICD C73 - Malignant neoplasm of thyroid gland | $3,666 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,443 | ||||
| Total Medicare payment per Hospitalization with ICD C73 - Malignant neoplasm of thyroid gland | $9,978 | ||||
| Total Medicare Charges at DRG | $271,493,595 | ||||
| Total Medicare Charges with ICD C73 - Malignant neoplasm of thyroid gland | $135,418,521 | ||||
| Avg Charges at DRG | $62,084 | ||||
| Avg Charges with ICD C73 - Malignant neoplasm of thyroid gland | $66,676 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| SNF Discharge Rate at DRG | 4.64 | ||||
| SNF Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 2.17 | ||||
| Home Discharge Rate at DRG | 84.36 | ||||
| Home Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 88.08 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 645: ENDOCRINE DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 643: ENDOCRINE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 849: RADIOTHERAPY | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 14,641 | ||||
| Total Hospitalizations with ICD C73 - Malignant neoplasm of thyroid gland | 418 | ||||
| DRG Share of Total Hospitalizations | 0.04 | ||||
| % of Total ICD C73 - Malignant neoplasm of thyroid gland in DRG | 2.45 | ||||
| Avg LOS at DRG | 3.27 | ||||
| Avg LOS with ICD C73 - Malignant neoplasm of thyroid gland | 2.22 | ||||
| Readmission Rate at DRG | 15.59 | ||||
| Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 5.12 | ||||
| Unplanned Readmission Rate at DRG | 10.71 | ||||
| Unplanned Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 3.84 | ||||
| Total Medicare payments at DRG | $65,110,974 | ||||
| Total Medicare payments with ICD C73 - Malignant neoplasm of thyroid gland | $1,817,329 | ||||
| Total Medicare payment per Day at DRG | $1,362 | ||||
| Total Medicare payment per Day with ICD C73 - Malignant neoplasm of thyroid gland | $1,954 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,447 | ||||
| Total Medicare payment per Hospitalization with ICD C73 - Malignant neoplasm of thyroid gland | $4,348 | ||||
| Total Medicare Charges at DRG | $357,303,965 | ||||
| Total Medicare Charges with ICD C73 - Malignant neoplasm of thyroid gland | $10,951,132 | ||||
| Avg Charges at DRG | $24,404 | ||||
| Avg Charges with ICD C73 - Malignant neoplasm of thyroid gland | $26,199 | ||||
| Mortality Rate at DRG | 0.08 | ||||
| Mortality Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| SNF Discharge Rate at DRG | 13.89 | ||||
| SNF Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| Home Discharge Rate at DRG | 62.89 | ||||
| Home Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 90.67 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 629: OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 15,548 | ||||
| Total Hospitalizations with ICD C73 - Malignant neoplasm of thyroid gland | 195 | ||||
| DRG Share of Total Hospitalizations | 0.05 | ||||
| % of Total ICD C73 - Malignant neoplasm of thyroid gland in DRG | 1.15 | ||||
| Avg LOS at DRG | 7.55 | ||||
| Avg LOS with ICD C73 - Malignant neoplasm of thyroid gland | 2.24 | ||||
| Readmission Rate at DRG | 25.61 | ||||
| Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 9.42 | ||||
| Unplanned Readmission Rate at DRG | 13.93 | ||||
| Unplanned Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| Total Medicare payments at DRG | $225,408,950 | ||||
| Total Medicare payments with ICD C73 - Malignant neoplasm of thyroid gland | $2,726,509 | ||||
| Total Medicare payment per Day at DRG | $1,921 | ||||
| Total Medicare payment per Day with ICD C73 - Malignant neoplasm of thyroid gland | $6,239 | ||||
| Total Medicare payment per Hospitalization at DRG | $14,498 | ||||
| Total Medicare payment per Hospitalization with ICD C73 - Malignant neoplasm of thyroid gland | $13,982 | ||||
| Total Medicare Charges at DRG | $1,165,672,078 | ||||
| Total Medicare Charges with ICD C73 - Malignant neoplasm of thyroid gland | $10,587,780 | ||||
| Avg Charges at DRG | $74,972 | ||||
| Avg Charges with ICD C73 - Malignant neoplasm of thyroid gland | $54,296 | ||||
| Mortality Rate at DRG | 0.19 | ||||
| Mortality Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| SNF Discharge Rate at DRG | 27.84 | ||||
| SNF Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| Home Discharge Rate at DRG | 27.39 | ||||
| Home Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 89.23 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 417,755 | ||||
| Total Hospitalizations with ICD C73 - Malignant neoplasm of thyroid gland | 174 | ||||
| DRG Share of Total Hospitalizations | 1.27 | ||||
| % of Total ICD C73 - Malignant neoplasm of thyroid gland in DRG | 1.02 | ||||
| Avg LOS at DRG | 3.9 | ||||
| Avg LOS with ICD C73 - Malignant neoplasm of thyroid gland | 4.23 | ||||
| Readmission Rate at DRG | 16.53 | ||||
| Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 22.36 | ||||
| Unplanned Readmission Rate at DRG | 11.52 | ||||
| Unplanned Readmission Rate with ICD C73 - Malignant neoplasm of thyroid gland | 19.88 | ||||
| Total Medicare payments at DRG | $2,493,587,688 | ||||
| Total Medicare payments with ICD C73 - Malignant neoplasm of thyroid gland | $1,097,793 | ||||
| Total Medicare payment per Day at DRG | $1,529 | ||||
| Total Medicare payment per Day with ICD C73 - Malignant neoplasm of thyroid gland | $1,492 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,969 | ||||
| Total Medicare payment per Hospitalization with ICD C73 - Malignant neoplasm of thyroid gland | $6,309 | ||||
| Total Medicare Charges at DRG | $11,318,800,289 | ||||
| Total Medicare Charges with ICD C73 - Malignant neoplasm of thyroid gland | $5,915,478 | ||||
| Avg Charges at DRG | $27,094 | ||||
| Avg Charges with ICD C73 - Malignant neoplasm of thyroid gland | $33,997 | ||||
| Mortality Rate at DRG | 0.87 | ||||
| Mortality Rate with ICD C73 - Malignant neoplasm of thyroid gland | NA | ||||
| SNF Discharge Rate at DRG | 17.03 | ||||
| SNF Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 13.22 | ||||
| Home Discharge Rate at DRG | 53.31 | ||||
| Home Discharge Rate with ICD C73 - Malignant neoplasm of thyroid gland | 54.02 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 287 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 154 |
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 142 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MARK EDWIN ZAFEREO | 1515 HOLCOMBE BLVD UNIT 1445 | HOUSTON | TX | 77030 | 56 |
| Dr. GARY LEE CLAYMAN | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 56 |
| Dr. JAN L KASPERBAUER | 200 1ST ST SW | ROCHESTER | MN | 55905 | 33 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MARK EDWIN ZAFEREO | 1515 HOLCOMBE BLVD UNIT 1445 | HOUSTON | TX | 77030 | 60 |
| Dr. GARY LEE CLAYMAN | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 59 |
| Dr. JAN L KASPERBAUER | 200 1ST ST SW | ROCHESTER | MN | 55905 | 33 |